Covid 19 Treatment

PharmAust share price soars on release of results

Finfeed Archived Jun 18, 2020

PharmAust (ASX: PAA) received positive news regarding the performance of its treatments in reducing SARS-CoV-2 (COVID-19)

Could PAA’s lead cancer drug treatment treat COVID-19?

Finfeed Archived Apr 17, 2020

PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.